Resonetics® Invests in Nitinol Gun Drilling Capabilities Through Purchase of Assets from Medical Component Specialists
Resonetics has acquired the nitinol gun drilling operations and related assets from Medical Component Specialists' (MCS) New Boston, NH facility. The acquisition strengthens Resonetics' U.S.-based nitinol strategy and enhances their supply chain resilience. Gun drilling, a specialized machining process creating precision holes in bars, is fundamental for producing high-performance nitinol tubing used in medical devices.
This move follows Resonetics' recent investments in melt capacity, raw materials, and the acquisition of former Memry Corp. and SAES Smart Materials, establishing the industry's most comprehensive nitinol portfolio. The company aims to improve material availability, reduce lead times, and maintain its position as an open-source supplier to medical device OEMs and contract manufacturers.
Resonetics ha acquisito le operazioni di foratura con canna rigata in nitinol e i relativi asset dalla struttura di Medical Component Specialists (MCS) a New Boston, NH. Questa acquisizione rafforza la strategia basata negli Stati Uniti sul nitinol di Resonetics e migliora la resilienza della loro catena di approvvigionamento. La foratura con canna rigata, un processo di lavorazione specializzato che crea fori di precisione nelle barre, è fondamentale per la produzione di tubi in nitinol ad alte prestazioni utilizzati nei dispositivi medici.
Questa mossa segue i recenti investimenti di Resonetics nella capacità di fusione, nelle materie prime e l'acquisizione delle ex Memry Corp. e SAES Smart Materials, stabilendo il portafoglio di nitinol più completo del settore. L'azienda punta a migliorare la disponibilità dei materiali, ridurre i tempi di consegna e mantenere la propria posizione come fornitore open-source per OEM di dispositivi medici e produttori a contratto.
Resonetics ha adquirido las operaciones de perforación con cañón de nitinol y los activos relacionados de la instalación de Medical Component Specialists (MCS) en New Boston, NH. La adquisición fortalece la estrategia de nitinol basada en EE.UU. de Resonetics y mejora la resiliencia de su cadena de suministro. La perforación con cañón, un proceso de mecanizado especializado que crea agujeros de precisión en barras, es fundamental para la producción de tubos de nitinol de alto rendimiento usados en dispositivos médicos.
Esta acción sigue a las recientes inversiones de Resonetics en capacidad de fusión, materias primas y la adquisición de las antiguas Memry Corp. y SAES Smart Materials, estableciendo el portafolio de nitinol más completo de la industria. La compañía busca mejorar la disponibilidad de materiales, reducir los tiempos de entrega y mantener su posición como proveedor de código abierto para OEMs de dispositivos médicos y fabricantes por contrato.
Resonetics는 Medical Component Specialists(MCS)의 뉴보스턴, NH 시설에서 니티놀 건 드릴링 작업 및 관련 자산을 인수했습니다. 이번 인수는 Resonetics의 미국 기반 니티놀 전략을 강화하고 공급망 복원력을 높입니다. 건 드릴링은 바(bar)에 정밀한 구멍을 뚫는 특수 가공 공정으로, 의료기기에 사용되는 고성능 니티놀 튜빙 생산에 필수적입니다.
이번 조치는 최근 Resonetics가 용융 능력, 원자재 투자 및 전 Memry Corp.와 SAES Smart Materials 인수를 통해 업계에서 가장 포괄적인 니티놀 포트폴리오를 구축한 데 이은 것입니다. 회사는 자재 공급을 개선하고 리드 타임을 단축하며 의료기기 OEM 및 계약 제조업체에 대한 오픈 소스 공급업체로서의 입지를 유지하는 것을 목표로 하고 있습니다.
Resonetics a acquis les opérations de forage à canon en nitinol ainsi que les actifs associés de l’installation de Medical Component Specialists (MCS) à New Boston, NH. Cette acquisition renforce la stratégie nitinol basée aux États-Unis de Resonetics et améliore la résilience de leur chaîne d’approvisionnement. Le forage à canon, un procédé d’usinage spécialisé créant des trous de précision dans des barres, est essentiel à la production de tubes en nitinol haute performance utilisés dans les dispositifs médicaux.
Cette démarche fait suite aux récents investissements de Resonetics dans la capacité de fusion, les matières premières, ainsi qu’à l’acquisition des anciennes Memry Corp. et SAES Smart Materials, établissant ainsi le portefeuille de nitinol le plus complet de l’industrie. L’entreprise vise à améliorer la disponibilité des matériaux, réduire les délais de livraison et maintenir sa position de fournisseur open source auprès des fabricants d’équipements d’origine (OEM) et des sous-traitants en dispositifs médicaux.
Resonetics hat die Nitinol-Kanonenbohrungsbetriebe und zugehörigen Vermögenswerte von der Medical Component Specialists (MCS) Anlage in New Boston, NH, übernommen. Die Übernahme stärkt die US-basierte Nitinol-Strategie von Resonetics und erhöht die Widerstandsfähigkeit ihrer Lieferkette. Kanonenbohren, ein spezialisierter Bearbeitungsprozess zur Herstellung präziser Löcher in Stangen, ist grundlegend für die Produktion von Hochleistungs-Nitinolrohren, die in medizinischen Geräten verwendet werden.
Dieser Schritt folgt auf Resonetics' jüngste Investitionen in Schmelzkapazitäten, Rohstoffe und die Übernahme der ehemaligen Memry Corp. und SAES Smart Materials, wodurch das umfassendste Nitinol-Portfolio der Branche geschaffen wurde. Das Unternehmen zielt darauf ab, die Materialverfügbarkeit zu verbessern, Lieferzeiten zu verkürzen und seine Position als Open-Source-Lieferant für OEMs von Medizinprodukten und Auftragshersteller zu festigen.
- Vertical integration through acquisition of critical gun drilling operations improves supply chain control
- Strengthens U.S.-based nitinol manufacturing capabilities
- Enhances ability to reduce lead times for customers
- Expands company's comprehensive nitinol portfolio
- None.
Insights
Resonetics strengthens its nitinol manufacturing capabilities through strategic acquisition, reinforcing vertical integration and reducing supply chain vulnerability.
Resonetics' acquisition of Medical Component Specialists' nitinol gun drilling operations represents a significant vertical integration move in their nitinol strategy. Gun drilling creates precision holes in metal bars - a critical first step in producing seamless-drawn nitinol tubing used in advanced medical devices.
This acquisition is particularly noteworthy as it follows Resonetics' previous investments in nitinol melt capacity and raw material inventory. By bringing this specialized manufacturing capability in-house, Resonetics gains three competitive advantages:
- Direct control over a critical supply chain component
- Reduced lead times for customers
- Enhanced quality control over a technically demanding process
The medical device industry relies heavily on nitinol - a nickel-titanium alloy with superelastic and shape memory properties ideal for implantable devices. The material enables minimally invasive procedures through its ability to navigate complex anatomies while maintaining strength.
This transaction aligns with the broader industry trend toward supply chain resilience in response to recent global disruptions. By owning more of their input production, Resonetics insulates itself from potential supplier issues while positioning for growth in premium nitinol tubing markets.
The company's emphasis on remaining an "open-source supplier" to both OEMs and contract manufacturers suggests they're positioning to capture value throughout the medical device manufacturing ecosystem rather than pursuing exclusive partnerships - a strategy that maximizes their addressable market.
Establishes nitinol input tube operation to support premium, implant-grade tubing initiative and strengthen supply chain resilience
Gun drilling is a highly specialized machining operation that creates a precision hole along the center of a bar. This foundational manufacturing step in the production of high-performance nitinol tubing serves as the starting point for seamless-drawn nitinol tubing.
MCS has been a supplier of nitinol input tubes in support of Resonetics' growing nitinol tubing business. MCS' automated long-stroke gun drilling process both drives efficiency and meets the exacting demands of the medical device industry.
"Nitinol gun drilling is critical to our premium tubing initiative and our ability to improve material availability and reduce lead times for our customers," said Kevin Kelly, CEO of Resonetics. "Combined with the recent investments we've made in melt capacity and raw material and in-process inventory, this acquisition further reduces supply chain risk - all while supporting our long-term growth and innovation in nitinol."
This investment also builds on Resonetics' recent nitinol tubing capability expansion in
"As we expand our tubing and component capabilities, we remain committed to being an open-source supplier to both medical device OEMs and contract manufacturers," added Kelly. "We welcome partnerships with customers of all sizes, and we're focused on delivering the quality, responsiveness, and innovation that accelerates medical device breakthroughs."
About Resonetics
Founded in 1987, Resonetics is a pioneer in advanced engineering and manufacturing solutions for the medical device industry. Resonetics is a leader in laser processing, nitinol manufacturing, thin-wall stainless steel, nitinol& precious metal tubing, and photochemical machining. With strategically located Lightspeed Labs® and AGILE Product Development® centers, Resonetics is committed to quality, speed, innovation, and a great customer experience. The company is ISO 13485:2016 certified with 17 facilities and more than 3,000 associates in
About GTCR
Founded in 1980, GTCR is a leading private equity firm that invests behind The Leaders Strategy™ – finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through organic growth and strategic acquisitions. GTCR is focused on investing in transformative growth in companies in the Business & Consumer Services, Financial Services & Technology, Healthcare and Technology, Media & Telecommunications sectors. Since its inception, GTCR has invested more than
About
View original content to download multimedia:https://www.prnewswire.com/news-releases/resonetics-invests-in-nitinol-gun-drilling-capabilities-through-purchase-of-assets-from-medical-component-specialists-302458719.html
SOURCE Resonetics, LLC
FAQ
What assets did Resonetics (CG) acquire from Medical Component Specialists in May 2025?
How does the MCS acquisition benefit Resonetics' nitinol production capabilities?
What is the strategic importance of nitinol gun drilling for Resonetics?
How does this acquisition fit into Resonetics' broader nitinol strategy?
